Vitalhub Corp. (TSE:VHI - Get Free Report) traded down 2.6% during trading on Thursday . The stock traded as low as C$7.20 and last traded at C$7.23. 187,463 shares changed hands during mid-day trading, a decline of 48% from the average session volume of 357,574 shares. The stock had previously closed at C$7.42.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the stock. National Bank Financial lowered their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an "outperform" rating for the company in a research report on Wednesday, May 27th. Raymond James Financial lowered their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating for the company in a research report on Tuesday, March 24th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of C$13.14.
Check Out Our Latest Stock Analysis on Vitalhub
Vitalhub Price Performance
The stock has a market cap of C$435.86 million, a price-to-earnings ratio of 57.42, a P/E/G ratio of 1.18 and a beta of 0.91. The business's fifty day simple moving average is C$7.21 and its 200 day simple moving average is C$7.77.
Vitalhub (TSE:VHI - Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 6.13% and a return on equity of 2.98%. The firm had revenue of C$31.91 million during the quarter. As a group, equities analysts forecast that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.
About Vitalhub
(
Get Free Report)
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
